Title of article
The Potential Role of Naltrexone in Borderline Personality Disorder
Author/Authors
Moghaddas, Azadeh Department of Clinical Pharmacy Faculty of Pharmacy - Isfahan University of Medical Sciences , Dianatkhah, Mehrnoush Department of Clinical Pharmacy - Faculty of Pharmacy - Tehran University of Medical Sciences , Ghaffari, Saba Department of Clinical Pharmacy - Faculty of Pharmacy - Tabriz University of Medical Sciences, , Ghaeli, Padideh Psychiatry and Psychology Research Center - Roozbeh Hospital and Faculty of Pharmacy - Tehran University of Medical Sciences
Pages
5
From page
142
To page
146
Abstract
Objective: Management of borderline personality disorder (BPD) is a difficult challenge due to the complex features of this disorder. This article reviews the use of naltrexone in the treatment of BPD.
Methods: Published articles and clinical trials were searched in Google Scholar, MedLine, ELSEVIER, and Cochrane database of systematic reviews abstracts in English language between 1990 and 2017.
Results: Naltrexone (NTX), a nonspecific competitive opiate antagonist, has been noted to be helpful in controlling self-injurious behavior (SIB) and dissociative symptoms in patients with BPD.
Conclusions: Further studies should be conducted on the effects of naltrexone to confirm the role of this medication in the treatment of BPD.
Keywords
Borderline Personality Disorder , Naltrexone , Self-injurious Behavior , Dissociative Symptoms , Psychiatry and Psychology Category
Journal title
Astroparticle Physics
Serial Year
2017
Record number
2419994
Link To Document